Literature DB >> 27556663

Treatment of Head and Neck Paragangliomas.

Kenneth Hu1, Mark S Persky.   

Abstract

BACKGROUND: Commonly occurring in the head and neck, paragangliomas are typically benign, highly vascular neoplasms embryologically originating from the extra-adrenal paraganglia of the neural crest. Frequently, these tumors are associated with the vagus or tympanic plexus nerve or the carotid artery, or jugular bulb. Their clinical presentation can vary across a wide spectrum of signs and symptoms.
METHODS: We reviewed and compared standard treatment approaches for paragangliomas of the head and neck.
RESULTS: In general, surgery is the first-line choice of therapy for carotid body tumors, whereas radiotherapy is the first-line option for jugular and vagal paragangliomas.
CONCLUSIONS: Because of the complexity of clinical scenarios and treatment options for paragangliomas, a multidisciplinary algorithmic approach should be used for treating paragangliomas. The approach should emphasize single-modality treatment that yields excellent rates of tumor control, low rates of severe, iatrogenic morbidity, and the preservation of long-term function in this patient population.

Entities:  

Mesh:

Year:  2016        PMID: 27556663     DOI: 10.1177/107327481602300306

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  12 in total

1.  Functional treatment of temporal bone chondroblastoma: retrospective analysis of 3 cases.

Authors:  Alessandro Vinciguerra; Benjamin Verillaud; Michaël Eliezer; Rachid Kaci; Romain Kania; Philippe Herman
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-13       Impact factor: 2.503

2.  Local Tumor Behavior Associated With Survival Among Patients With Paraganglioma of the Head and Neck.

Authors:  Randall J Harley; Jason H Lee; Benjamin T Ostrander; Andrey Finegersh; Tammy B Pham; Kareem O Tawfik; Yin Ren; Farhoud Faraji; Rick A Friedman
Journal:  OTO Open       Date:  2022-03-31

3.  Texture analysis of T2-weighted MRI predicts SDH mutation in paraganglioma.

Authors:  Shotaro Naganawa; John Kim; Stephen S F Yip; Yoshiaki Ota; Ashok Srinivasan; Toshio Moritani
Journal:  Neuroradiology       Date:  2020-11-19       Impact factor: 2.804

4.  Evaluation of Skull Base Tumors with Dynamic TurboFLASH MRI during Gadolinium Injection.

Authors:  Guido Trasimeni; Marina Auconi; Andrea Grossi; Olga Gagliardo; Andrea Romano; Edoardo Covelli; Alessandro Bozzao
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-15

5.  A 10-year experience of linear accelerator-based stereotactic radiosurgery/radiotherapy (SRS/SRT) for paraganglioma: A single institution experience and review of the literature.

Authors:  Michael J Gigliotti; Shaakir Hasan; Yun Liang; Douglas Chen; Russell Fuhrer; Rodney E Wegner
Journal:  J Radiosurg SBRT       Date:  2018

6.  Preoperative embolization of jugular paraganglioma tumors using particles is safe and effective.

Authors:  Ahmed Helal; Kunal Vakharia; Waleed Brinjikji; Matthew L Carlson; Colin Lw Driscoll; Jamie J Van Gompel; Michael J Link; Harry Cloft
Journal:  Interv Neuroradiol       Date:  2021-05-26       Impact factor: 1.764

7.  Head and neck paragangliomas: A two-decade institutional experience and algorithm for management.

Authors:  Joshua D Smith; Rachel N Harvey; Owen A Darr; Mark E Prince; Carol R Bradford; Gregory T Wolf; Tobias Else; Gregory J Basura
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-11-11

8.  Anesthetic approaches in carotid body tumor surgery.

Authors:  Ali Sait Kavakli; Nilgun Kavrut Ozturk
Journal:  North Clin Istanb       Date:  2016-11-21

9.  Case of Incidental Asymptomatic Carotid Body Paraganglioma in a Patient with Infectious Mononucleosis.

Authors:  Eric L Cox; Anthony Diponio; David Seel
Journal:  Cureus       Date:  2019-08-20

10.  An unusual combined glomus vagale and jugular tumor: A case report.

Authors:  Oukessou Youssef; Abdulhakeem Bushra; Regragui Meryem; Hammouda Yassir; El Bouhmadi Khadija; Rouadi Sami; Abada Redallah; Roubal Mohamed; Mahtar Mohamed
Journal:  Ann Med Surg (Lond)       Date:  2021-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.